2022 Q1 Form 10-K Financial Statement
#000164033422001390 Filed on June 29, 2022
Income Statement
Concept | 2022 Q1 | 2022 | 2021 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | $0.00 | ||
YoY Change | |||
Gross Profit | $0.00 | ||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $118.7K | $472.8K | $116.1K |
YoY Change | 2.26% | 65.04% | 114.63% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $18.64K | $74.90K | $73.04K |
YoY Change | -74.48% | 2.55% | |
% of Gross Profit | |||
Operating Expenses | $118.7K | $472.8K | $116.1K |
YoY Change | 2.26% | 65.04% | 114.63% |
Operating Profit | -$472.8K | ||
YoY Change | 65.04% | ||
Interest Expense | $0.00 | $1.00 | $0.00 |
YoY Change | 0.0% | -100.0% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$170.00 | -$417.00 | $170.00 |
YoY Change | -200.0% | -349.7% | -41.38% |
Pretax Income | -$118.8K | -$473.2K | -$115.9K |
YoY Change | 2.55% | 65.28% | 110.59% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$118.8K | -$473.2K | -$115.9K |
YoY Change | 2.55% | 65.28% | 110.59% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$59.91K | -$238.6K | -$11.69K |
COMMON SHARES | |||
Basic Shares Outstanding | 9.918M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q1 | 2022 | 2021 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $530.00 | $530.00 | $300.00 |
YoY Change | 76.67% | 76.67% | -61.54% |
Cash & Equivalents | $525.00 | $530.00 | $300.00 |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $6.840K | $6.840K | $1.995K |
YoY Change | 242.86% | 242.0% | 15.99% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $6.480K | $6.480K | $79.64K |
YoY Change | -91.86% | -91.86% | -32.06% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $6.481K | $6.480K | $79.64K |
YoY Change | -91.86% | -91.86% | -32.06% |
TOTAL ASSETS | |||
Total Short-Term Assets | $6.840K | $6.840K | $1.995K |
Total Long-Term Assets | $6.481K | $6.480K | $79.64K |
Total Assets | $13.32K | $13.32K | $81.63K |
YoY Change | -83.68% | -83.68% | -31.37% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $177.4K | $177.4K | $99.69K |
YoY Change | 77.95% | 77.95% | -15.99% |
Accrued Expenses | $26.48K | $26.48K | $98.53K |
YoY Change | -73.12% | -73.12% | 18.61% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $228.7K | $228.7K | $171.7K |
YoY Change | 33.21% | 33.21% | 5.76% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.458M | $2.458M | $2.025M |
YoY Change | 21.37% | 21.37% | 20.83% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.458M | $2.458M | $2.025M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $2.458M | $2.458M | $2.025M |
YoY Change | 21.37% | 21.37% | 17.61% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$2.401M | -$1.928M | |
YoY Change | 24.54% | ||
Common Stock | $1.984K | $1.984K | |
YoY Change | 0.0% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$2.444M | -$2.444M | -$1.943M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $13.32K | $13.32K | $81.63K |
YoY Change | -83.68% | -83.68% | -31.37% |
Cashflow Statement
Concept | 2022 Q1 | 2022 | 2021 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$118.8K | -$473.2K | -$115.9K |
YoY Change | 2.55% | 65.28% | 110.59% |
Depreciation, Depletion And Amortization | $18.64K | $74.90K | $73.04K |
YoY Change | -74.48% | 2.55% | |
Cash From Operating Activities | -$35.36K | -$172.8K | -$163.4K |
YoY Change | -78.36% | -50.38% | -289.99% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cash From Investing Activities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 35.27K | $173.0K | 163.2K |
YoY Change | -78.39% | -50.25% | -290.5% |
NET CHANGE | |||
Cash From Operating Activities | -35.36K | -$172.8K | -163.4K |
Cash From Investing Activities | 0.000 | $0.00 | 0.000 |
Cash From Financing Activities | 35.27K | $173.0K | 163.2K |
Net Change In Cash | -90.00 | $225.00 | -170.0 |
YoY Change | -47.06% | -147.37% | -153.13% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$35.36K | -$172.8K | -$163.4K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Auditor Location
AuditorLocation
|
New York | |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
525 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
300 | USD |
CY2022Q1 | us-gaap |
Other Receivables
OtherReceivables
|
6315 | USD |
CY2021Q1 | us-gaap |
Other Receivables
OtherReceivables
|
1695 | USD |
CY2022Q1 | us-gaap |
Assets Current
AssetsCurrent
|
6840 | USD |
CY2021Q1 | us-gaap |
Assets Current
AssetsCurrent
|
1995 | USD |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
6481 | USD |
CY2021Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
79635 | USD |
CY2022Q1 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
6481 | USD |
CY2021Q1 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
79635 | USD |
CY2022Q1 | us-gaap |
Assets
Assets
|
13321 | USD |
CY2021Q1 | us-gaap |
Assets
Assets
|
81630 | USD |
CY2022Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
177395 | USD |
CY2021Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
99692 | USD |
CY2022Q1 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
0 | USD |
CY2021Q1 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
87202 | USD |
CY2022Q1 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
228675 | USD |
CY2021Q1 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
171666 | USD |
CY2022Q1 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
480 | USD |
CY2021Q1 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
470 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
26003 | USD |
CY2021Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
98526 | USD |
CY2022Q1 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
2025195 | USD |
CY2021Q1 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
1567380 | USD |
CY2022Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2457748 | USD |
CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2024936 | USD |
CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
0 | USD |
CY2021Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
0 | USD |
CY2022Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
0 | USD |
CY2021Q1 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
0 | USD |
CY2022Q1 | us-gaap |
Liabilities
Liabilities
|
2457748 | USD |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
2024936 | USD |
CY2022Q1 | elre |
Commitment And Contingency
CommitmentAndContingency
|
0 | USD |
CY2021Q1 | elre |
Commitment And Contingency
CommitmentAndContingency
|
0 | USD |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
3000000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1983518 | shares |
CY2022Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1984 | USD |
CY2021Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
1984 | USD |
CY2022Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
7934 | USD |
CY2021Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
7934 | USD |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2401469 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2444427 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1943306 | USD |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1928249 | USD |
CY2022Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-52876 | USD |
CY2021Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-24975 | USD |
CY2022Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13321 | USD |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
81630 | USD |
CY2021 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2022 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
416283 | USD |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
211426 | USD |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
56520 | USD |
CY2021 | us-gaap |
Professional Fees
ProfessionalFees
|
75055 | USD |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
472803 | USD |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
286481 | USD |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-472803 | USD |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-286481 | USD |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
1 | USD |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
1 | USD |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-418 | USD |
CY2021 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
166 | USD |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-417 | USD |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
167 | USD |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-473220 | USD |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-286314 | USD |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-473220 | USD |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-286314 | USD |
CY2022 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-27901 | USD |
CY2021 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-54209 | USD |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-501121 | USD |
CY2021 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-340523 | USD |
CY2022 | elre |
Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
|
-0.24 | |
CY2021 | elre |
Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
|
-0.14 | |
CY2022 | elre |
Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
|
1983518 | shares |
CY2021 | elre |
Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
|
1983518 | shares |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1602783 | USD |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-286314 | USD |
CY2021 | us-gaap |
Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
|
-54209 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1943306 | USD |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-473220 | USD |
CY2022 | us-gaap |
Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
|
-27901 | USD |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2444427 | USD |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-473220 | USD |
CY2022 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
74895 | USD |
CY2022 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
4508 | USD |
CY2022 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
53179 | USD |
CY2021 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-80421 | USD |
CY2022 | us-gaap |
Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
|
-74895 | USD |
CY2021 | us-gaap |
Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
|
-66953 | USD |
CY2022 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
-251778 | USD |
CY2020Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
775 | USD |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
525 | USD |
CY2022Q1 | us-gaap |
Due From Related Parties
DueFromRelatedParties
|
228675 | USD |
CY2022 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
0 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
300 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
300 | USD |
CY2022 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2021 | us-gaap |
Interest Paid
InterestPaid
|
0 | USD |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
CY2007Q1 | elre |
Common Stock Increase Authorized Capital Shares
CommonStockIncreaseAuthorizedCapitalShares
|
1000000000 | shares |
CY2022 | elre |
State Or Jurisdiction Of Organisation Of Entity
StateOrJurisdictionOfOrganisationOfEntity
|
British Virgin Island | |
CY2022 | elre |
Attributable Equity Interest
AttributableEquityInterest
|
1 | pure |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. </p> | |
CY2021Q1 | us-gaap |
Due From Related Parties
DueFromRelatedParties
|
171666 | USD |
CY2022 | us-gaap |
Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the Consolidated Balance Sheet as of March 31, 2021 to reclassify short-term loan of $171,666 to short-term loan - related party; and reclassify other payable of $470 to accrued interest -related party.</p> | |
CY2021Q1 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
171666 | USD |
CY2021Q1 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
470 | USD |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
|
27901 | USD |
CY2021 | us-gaap |
Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
|
54209 | USD |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p> | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-473220 | USD |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-286314 | USD |
CY2022 | elre |
Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
|
1983518 | shares |
CY2021 | elre |
Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
|
1983518 | shares |
CY2022 | elre |
Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
|
-0.24 | |
CY2021 | elre |
Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
|
-0.14 | |
CY2021Q1 | elre |
Accrued Interest Related Parties
AccruedInterestRelatedParties
|
470 | USD |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2401469 | USD |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-473220 | USD |
CY2022 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-172771 | USD |
CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
3000000000 | shares |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1983518 | shares |
CY2022Q1 | elre |
Accrued Interest Related Parties
AccruedInterestRelatedParties
|
480 | USD |
CY2022 | elre |
Incremental Borrowing Rate
IncrementalBorrowingRate
|
4.75 | |
CY2022 | elre |
Operating Lease Expenses
OperatingLeaseExpenses
|
74895 | USD |
CY2021 | elre |
Operating Lease Expenses
OperatingLeaseExpenses
|
73040 | USD |
CY2020Q3 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
143508 | USD |
CY2017Q4 | us-gaap |
Income Tax Examination Description
IncomeTaxExaminationDescription
|
The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. As a result of the reduction in the U.S. corporate income tax rate from 34% to 21% under the Tax Reform Act, the Company revalued its ending net deferred tax assets. |